Blog

Discover the best analytics platform – as used by the best providers of Pharma data analytics

For the sixth year running, Tableau – the ‘enterprise analytics platform that people love and IT trusts’ (tableau.com) is leading the way in American research and advisory firm, Gartner’s, analysis of software platforms.

Since launching our RX Analyser tool, Tableau has been our development platform of choice because it allows you to see and understand data with ease.

And, when it comes to analysing pharmaceutical data, Tableau is invaluable. We use it to offer:

RX Analyser

RX Analyser gives you the power to transform NHS and IMS prescribing data into a rich source of primary and secondary care information.

The software delivers rapid-fire, easy-to-analyse visualisations, enabling you to drill down to the key data sets you need

Salesview

Salesview enables pharmaceutical companies to understand how and where the NHS prescribes their products and their competitor’s products.

The tool provides a comprehensive analysis of the competitive prescribing landscape, giving valuable insight into product portfolios down to GP practice level.

Marketview

Marketview enables pharmaceutical companies to analyse the current prescribing of a new or potential product and help to develop a market entry strategy.

The tool provides comprehensive analysis for both NHS and pharmaceutical companies of the UK prescribing market, giving valuable insight down to CCG level.

CCGView

Our CCGView tool provides a comprehensive analysis of the detailed prescribing for an NHS CCG or LHB, down to GP practice level.

Budget Impact Models

The RXA Budget Impact Model enables pharmaceutical companies to use the NHS’s own data to produce realistic and plausible cost saving prescribing switch strategies.

Forecaster

The RXA Forecaster tool produces forecasts of the predicted sales of pharmaceutical companies’ product portfolios, based on historic prescribing trends.

With the RXA Forecaster, you can plan for the future, set sales targets and keep track of sales activity at territory and CCG levels.

Why Tableau?

With the Tableau platform, Inspiremed’s RX Analyser enables you to answer questions, share insights, and analyse data of any size, from any source, on any computing platform.

“With Tableau, our RX Analyser tool can take big data and transform it from a raw, unwieldy format into a clear, easy to read and digestible format that’s easy to interpret.”

David Warwick, Director

To find out more, contact us 01600 891594 or email info@inspire-med.co.uk 

“One of the simplest dashboards I have used, this product is very flexible. We use it extensively to gain insight into our business, down to a CCG level.”

National Sales Manager, Leading Pharmaceutical Company, 2016

“Key benefits? Simple graphics that are easy to use in presentations. Easy to download. And the level of available detail – down to GP practice.”

Senior Manager, Global Healthcare Company, 2016

“Our sales team use RX Analyser to analyse results and opportunity; it’s used by management to measure performance and identify national trends to drive targeting and strategy.”

National Sales Manager, UK Pharmaceutical Company

“Analyser makes drilling down to the information I need to make key marketing decisions simpler and more targeted. Rx Analyser is both functional and elegant and is backed up by the can-do attitude of the Inspiremed team.”

Group Product Manager, Leading Pharmaceutical Company

“I use the data from RXA Budget Impact Model daily. It is the core of everything we do! I cannot recommend the model more. It has had a substantial impact on our business across the board and I would not be without it.”

Country Manager UK, Leading Diagnostics Company

“Customers tell us our platform has changed the way they work, that they’ve enhanced the strategies they implement, based on the work they’ve done with the analyser tool and that – bottom line – we’ve helped them to increase their sales. That’s a pretty good result from a chance cup of coffee.”

Andrew Norman and David Warwick, Directors

Sign up for added insights